COFEPRIS warns about risks in illegal cannabis products
Will 2025 be the year Mexico finally takes the step towards comprehensive legislation? The answer could be closer than it seems.
Claudia Sheinbaum criticized the company Paradise, related to Vicente Fox, for marketing CBD products without Cofepris authorization. She assured that any substance not recognized by the Commission is subject to sanctions.
This call comes in a context where the Mexican government reinforces its control over cannabis-derived products, warning of health risks when they do not comply with regulations.
420 LATAM present at the 1st Psychedelic Science Medical Symposium.
We attended the 1st Medical Symposium on Psychedelic Science, Carlos Alberto Leon and Ricardo Almanza, learned, shared and reinforced our vision of a future with ancestral knowledge.o Almanza, learned, shared and reinforced our vision of a future with ancestral knowledge.
The Challenge of Marketing in the Cannabis Industry
The cannabis industry is transforming, shifting from taboo to innovation. Brands like 420 Latam lead with ethical strategies, education, minimalist design, and transparency, building trust and standing out in a competitive and evolving market.
Innovations in Cultivation and Quality: How 420 LATAM Leads the Global Cannabis Market
In a fast-paced global market, innovation and excellence are the keys to success. 420 Latam is transforming the cannabis industry with advanced cultivation techniques and a continuous focus on improving its flowers and derivative products. From plant genetics to exports in key markets, our commitment is to offer sustainable, high-quality solutions that meet regulatory and consumer demands.
2024: A Year of Global Expansion for 420 Latam / Anutea in the Cannabis Market
This 2024 has been a year of transformation for 420 Latam / Anutea and cannabis agronomy in Colombia. We embarked on an ambitious global expansion, exploring emerging markets and establishing strategic relationships to bring Colombian cannabis flowers to new horizons.
Specific Proposal for the Reclassification of Cannabis in the 1961 Single Convention
Reclassify cannabis from Schedule I to Schedule II to acknowledge its therapeutic benefits while keeping strict controls. A new Schedule III category would allow easier access to low-abuse cannabis products, like those high in CBD.
Proposed Amendment to the Single Convention on Narcotic Drugs of 1961
Reclaiming the therapeutic potential of cannabis requires modern regulation that protects public health and reflects scientific advances and international recommendations.
Medical Cannabis Interview with Ricardo Almanza, CEO of 420 Latam for RTQ
Interview for Radio y Televisión Querétaro (RTQ) with CEO Ricardo, who shares his experiences on the subject of global cannabis.
Ricardo Almanza. The first Mexican to export Medical Cannabis to Europe.
Ricardo is a faithful believer that this plant and nature in general have always been there to heal us in body, mind and soul.
Wellness is more than a Trend; it is a Lifestyle. How Can Cannabis Contribute to Holistic Wellness?
In a world where wellness has become a priority, more people are looking for ways to improve their quality of life holistically.
How can Europe effectively balance cannabis regulation with public health priorities?
The European Drug Report 2024 highlights a crucial challenge: cannabis remains the most widely used illicit drug in Europe.
Benefits of Cannabis for End-of-Life Care
End-of-life care, also known as palliative care, focuses on improving the quality of life of patients facing terminal illness.